Immunopathogenic pathways in canine inflammatory myopathies resemble human myositis

Veterinary Immunology and Immunopathology

Volumn 113, Issue 1-2, 2006, Pages 200-214

  Shelton, G Diane ^a   Hoffman, Eric P ^b   Ghimbovschi, Svetlana ^b   Peters, Iain R ^c   Day, Michael J ^c   Mullins, Marissa ^d   Moore, Peter F ^e   Nagaraju, Kanneboyina ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Autoimmunity; Dog; Gene expression; Inflammation; Muscle

Indexed keywords

IMMUNOGLOBULIN;

ADAPTATION; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTATION; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CELL ACTIVATION; CELL GROWTH; CELL MATURATION; CELL MIGRATION; CONTROLLED STUDY; DENDRITIC CELL; DOG; FEMALE; GENE EXPRESSION; GENETIC REGULATION; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOGENESIS; INFLAMMATION; INNATE IMMUNITY; LYMPHOCYTE MIGRATION; MACROPHAGE ACTIVATION; MALE; MICROARRAY ANALYSIS; MUSCLE BIOPSY; MYOSITIS; NONHUMAN; NUCLEOTIDE SEQUENCE; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION;

ANIMALS; B-LYMPHOCYTES; BIOPSY; COMPLEMENT PATHWAY, CLASSICAL; CYTOKINES; DISEASE MODELS, ANIMAL; DOG DISEASES; DOGS; FEMALE; GENE EXPRESSION PROFILING; HUMANS; IMMUNOGLOBULINS; IMMUNOHISTOCHEMISTRY; MALE; MUSCLE, SKELETAL; MYOSITIS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

ANIMALIA; CANIS FAMILIARIS;

EID: 33746270199     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetimm.2006.05.005     Document Type: Article

References (43)

1. Bonnefont-Rebeix C., de Carvalho C.M., Bernaud J., Chabanne L., Marchal T., and Rigal D. CD86 molecule is a specific marker for canine monocyte-derived dendritic cells. Vet. Immunol. Immunopathol. 109 (2006) 167-176
2. Border W.A., and Ruoslahti E. Transforming growth factor-beta 1 induces extracellular matrix formation in glomerulonephritis. Cell Differ. Dev. 32 (1990) 425-431
3. Cobbold S., and Metcalfe S. Monoclonal antibodies that define canine homologues of human CD antigens: summary of the First International Canine Leukocyte Antigen Workshop (CLAW). Tissue Antigens 43 (1994) 137-154
4. Comalada M., Cardo M., Xaus J., Valledor A.F., Lloberas J., Ventura F., and Celada A. Decorin reverses the repressive effect of autocrine-produced TGF-β on mouse macrophage activation. J. Immunol. 170 (2003) 4450-4456
5. Danilenko D.M., Moore P.F., and Rossitto P.V. Canine leukocyte cell adhesion molecules (LeuCAMs): characterization of the CD11/CD18 family. Tissue Antigens 40 (1992) 13-21
6. Engel A.G., and Hohlfeld R. The polymyositis and dermatomyositis syndromes. In: Engel A.G., and Franzini-Armstrong C. (Eds). Myology (2004), McGraw-Hill, New York 1321-1366
7. Evans J., Levesque D., and Shelton G.D. Canine inflammatory myopathies: a clinicopathologic review of 200 cases. J. Vet. Intern. Med. 18 (2004) 679-691
8. Figarella-Branger D., Civatte M., Bartoli C., and Pellissier J.F. Cytokines, chemokines, and cell adhesion molecules in inflammatory myopathies. Muscle Nerve 28 (2003) 659-682
9. Fukushima K., Badlani N., Usas A., Riano F., Fu F., and Huard J. The use of an antifibrosis agent to improve muscle recovery after laceration. Am. J. Sports Med. 29 (2001) 394-402
10. Greenberg S.A., Sanoudou D., Haslett J.N., Kohane I.S., Kunkel L.M., Beggs A.H., and Amato A.A. Molecular profiles of inflammatory myopathies. Neurology 59 (2002) 1170-1182
11. Greenberg S.A., Pinkus J.L., Pinkus G.S., Burleson T., Sanoudou D., Tawil R., Barohn R.J., Saperstein D.S., Briemberg H.R., Ericsson M., Park P., and Amayo A.A. Interferon-α/β-mediated innate immune mechanisms in dermatomyositis. Ann. Neurol. 57 (2005) 664-678
12. Hankel, S., Shelton, G.D., Engvall, E., in press. Sarcolemma-specific autoantibodies in canine inflammatory myopathy. Vet. Immunol. Immunopathol., doi:10.1016/j.vetimm.2006.03.025.
13. Hoffman E.P., Deepak R., and Pachman L.M. Clarifying the boundaries between the inflammatory and dystrophic myopathies: insights from molecular diagnostics and microarrays. Rheum. Dis. Clin. N. Am. 28 (2002) 743-757
14. Isaka Y., Brees D.K., Ikegaya K., Kaneda Y., Imai E., Noble N.A., and Border W.A. Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney. Nat. Med. 2 (1996) 418-423
15. Lemke G., and Lu Q. Macrophage regulation by Tyro 3 family receptors. Curr. Opin. Immunol. 15 (2003) 31-36
16. Li Y., Foster W., Deasy B.M., Chan Y., Prisk V., Tang Y., Cummins J., and Huard J. Transforming growth factor-beta 1 induces the differentiation of myogenic cells into fibrotic cells in injured skeletal muscle: a key event in muscle fibrogenesis. Am. J. Pathol. 164 (2004) 1007-1019
17. Lundberg I., Ulfgren A.K., Nyberg P., Andersson U., and Klareskog L. Cytokine production in muscle tissue of patients with idiopathic inflammatory myopathies. Arthritis Rheum. 40 (1997) 865-874
18. Melmed C., Shelton G.D., Bergman R., and Barton C. Masticatory muscle myositis: pathogenesis, diagnosis, and treatment. Comp. Cont. Ed. Pract. Vet. 26 (2004) 590-605
19. Moore P.F., Rossitto P.V., Danilenko D.M., Wielenga J.J., Raff R.F., and Severns E. Monoclonal antibodies specific for canine CD4 and CD8 define functional T-lymphocyte subsets and high-density expression of CD4 by canine neutrophils. Tissue Antigens 40 (1992) 75-85
20. Moore P.F., Schrenzel M.D., Affloter V.K., Olivry T., and Naydan D. Canine cutaneous histiocytoma is an epidermotrophic Langerhans cell histiocytosis that expresses CD1 and specific beta 2-integrin molecules. Am. J. Pathol. 148 (1996) 1699-1708
21. Nagaraju K., Raben N., Villalba M.L., Danning C., Loeffler L.A., Lee E., Tresser N., Abati A., Fetsch P., and Plotz P.H. Costimulatory markers in muscle of patients with idiopathic inflammatory myopathies and in cultured muscle cells. Clin. Immunol. 92 (1999) 161-169
22. Nagaraju K. Immunological capabililties of skeletal muscle cells. Acta Physiol. Scand. 171 (2001) 215-223
23. Nagaraju K., and Plotz P.H. Animal models of myositis. Rheum. Dis. Clin. N. Am. 28 (2002) 917-933
24. Nagaraju K., Casciola-Rosen L., Lundberg I., Rashmi R., Cutting S., Thapliyal R., Chang J., Dwivedi S., Mitsak M., Chen Y.W., Plotz P., Rosen A., Hoffman E., and Raben N. Activation of the endoplasmic reticulum stress response in autoimmune myositis. Potential role in muscle fiber damage and dysfunction. Arthritis Rheum. 52 (2005) 1824-1835
25. Nielsen C.H., and Leslie R.G. Complement's participation in acquired immunity. J. Leukoc. Biol. 72 (2002) 249-261
26. Orvis J.A., and Cardinet III G.H. Canine muscle fiber types and susceptibility of masticatory muscles to myositis. Muscle Nerve 4 (1981) 354-359
27. Ostrander E.A., and Giniger E. Semper fidelis: what man's best friend can teach us about human biology and disease. Am. J. Hum. Genet. 61 (1997) 475-480
28. Page G., Chevrel G., and Miossec P. Anatomic localization of immature and mature dendritic cell subsets in dermatomyositis and polymyositis. Interaction with chemokines and Th1 cytokine-producing cells. Arthritis Rheum. 50 (2004) 199-208
29. Peters I.R., Helps C.R., Calvert E.L., Hall E.J., and Day M.J. Identification of four allelic variants of the dog IGHA gene. Immunogenetics 56 (2004) 254-260
30. Peters I.R., Helps C.R., Hall E.J., and Day M.J. Real-time RT-PCR: considerations for efficient and sensitive assay design. J. Immunol. Meth. 286 (2004) 203-217
31. Plotz P.H. The autoantibody repertoire: searching for order. Nat. Rev. Immunol. 3 (2003) 73-78
32. Pumarola M., Moore P.F., and Shelton G.D. Canine inflammatory myopathy: analysis of cellular infiltrates. Muscle Nerve 29 (2004) 782-789
33. Raju R., and Dalakas M.C. Gene expression profile in the muscles of patients with inflammatory myopathies: effect of therapy with IVIg and biological validation of clinically relevant genes. Brain 128 (2005) 1887-1896
34. Salvadori C., Peters I.R., Day M.J., Engvall E., and Shelton G.D. Muscle regeneration, inflammation, and connective tissue expansion in canine inflammatory myopathy. Muscle Nerve 31 (2005) 192-198
35. Shelton G.D., Bandman E., and Cardinet III G.H. Electrophoretic comparison of myosins from masticatory muscles and selected limb muscles in the dog. Am. J. Vet. Res. 46 (1985) 493-498
36. Shelton G.D., Cardinet III G.H., and Bandman E. Canine masticatory muscle disorders: a study of 29 cases. Muscle Nerve 10 (1987) 753-766
37. Tezak Z., Hoffman E.P., Lutz J.L., Fedczyna T.O., Stephan D., Bremer E.G., Kransnoselska-Riz I., Kumar A., and Pachman L.M. Gene expression profiling in DQA1*0501+ children with untreated dermatomyositis: a novel model of pathogenesis. J. Immunol. 168 (2002) 4154-4163
38. Tumor Analysis Best Practices Working Group. Expression profiling-best practices for data generation and interpretation in clinical trials. Nat. Rev. Genet. 5 (2004) 229-237
39. Wiendl H., Lautwein A., Mitsdorffer M., Krause S., Erfurth S., Wienhold W., Morgalla M., Weber E., Overkleeft H.S., Lochmuller H., Melms A., Tolosa E., and Driessen C. Antigen processing and presentation in human muscle: cathepsin S is critical for MHC class II expression and upregulated in inflammatory myopathies. J. Neuroimmunol. 138 (2003) 132-143
40. Wiendl H., Hohlfeld R., and Kieseier B.C. Immunobiology of muscle: advances in understanding an immunological microenvironment. Trends Immunol. 26 (2005) 373-380
41. Yamaguchi Y., Mann D.M., and Ruoslahti E. Negative regulation of transforming growth factor-beta by the proteoglycan decorin. Nature 346 (1990) 281-284
42. Yang S., and Sim C.K. New forms of dog CD80 and CD86 transcripts that encode secreted B7 molecules. Immunogenetics 50 (1999) 349-353
43. Zanotti S., Negri T., Cappelletti C., Bernasconi P., Canioni E., Di Blasi C., Pegoraro E., Angrlini C., Ciscato P., Prelle A., Mantegazza R., Morandi L., and Mora M. Decorin and biglycan expression is differentially altered in several muscular dystrophies. Brain 128 (2005) 2546-2555